Vedder Thinking | Articles Vedder Price Attorneys Author Article in the January 2013 Issue of Pharmaceutical Patent Analyst
Vedder Price Shareholders Thomas J. Kowalski and Deborah L. Lu, Ph.D., and Counsel Samuel H. Megerditchian recently authored the article “US Patent Law and the Attorney-Client Privilege,” published in Pharmaceutical Patent Analyst. The article, which explores attorney-client privilege as it relates to patent attorneys, includes information on memoranda and draft patent applications. It also provides discussion on a number of ways that the attorney-client privilege may be lost. Additionally, the article focuses on how the scope and availability of the attorney-client privilege varies widely around the world.
Pharmaceutical Patent Analyst, a print and online journal published by Future Science Ltd., features high-impact patent reviews and related discussions covering the recent developments in patent literature relevant to all areas of pharmaceutical and medical science.
To read this article in its entirety, please click here.